Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has completed the previously disclosed ...

After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...

BD (NYSE: BDX) shares dipped before hours today despite first-quarter results that came in ahead of the consensus Wall Street ...

BD is recognized as one of the leading medical technology companies worldwide, with a substantial market capitalization of $59.35 billion and annual revenue exceeding $20.6 billion. The company is ...

Medical tech company BD (Becton, Dickinson and Co.) acquired MedKeeper, a provider of cloud-based pharmacy management applications, the Franklin Lakes firm announced July 28. The deal – terms of which ...

Waters plans to combine with the Biosciences & Diagnostic Solutions business of BD (Becton, Dickinson & Co.), the companies said, in a $17.5 billion deal that would be the year’s largest within life ...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) reported Q4 CY2025 results , with sales up 1.6% year on year to $5.25 billion. Its non-GAAP profit of $2.91 per share was 3.5% above ...

Company’s latest solutions are designed to empower healthcare providers across the Middle East region, strengthen patient ...

FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE:BDX), a prominent global medical technology firm, confirmed today the completion of its acquisition of Edwards Lifesciences (NYSE:EW)' ...

Dubai, United Arab Emirates – The Dubai branch of BD (Becton, Dickinson, and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will mark its presence at Arab ...

Becton Dickinson & Co. is set to make additional investments in its U.S. manufacturing network to add capacity for critical medical devices. “BD has a longstanding history as a leading U.S.